Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro

被引:33
|
作者
Govindan, Suresh [1 ]
Sarkey, Jason [1 ]
Ji, Xiang [1 ]
Sundaresan, Nagalingam R. [2 ]
Gupta, Mahesh P. [2 ]
de Tombe, Pieter P. [1 ]
Sadayappan, Sakthivel [1 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA
[2] Univ Chicago, Dept Surg, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
Proteolysis; Pathogenesis; Muscle contractility; Actin; Acetylation; Ca2+; Transients; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MYBP-C; REGULATORY DOMAIN; HEART-MUSCLE; F-ACTIN; PHOSPHORYLATION; TROPONIN; CONTRACTILITY; ACTIVATION; BIOMARKER;
D O I
10.1007/s10974-012-9292-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiac myosin binding protein-C (cMyBP-C) plays a role in sarcomeric structure and stability, as well as modulating heart muscle contraction. The 150 kDa full-length (FL) cMyBP-C has been shown to undergo proteolytic cleavage during ischemia-reperfusion injury, producing an N-terminal 40 kDa fragment (mass 29 kDa) that is predominantly associated with post-ischemic contractile dysfunction. Thus far, the pathogenic properties of such truncated cMyBP-C proteins have not been elucidated. In the present study, we hypothesized that the presence of these 40 kDa fragments is toxic to cardiomyocytes, compared to the 110 kDa C-terminal fragment and FL cMyBP-C. To test this hypothesis, we infected neonatal rat ventricular cardiomyocytes and adult rabbit ventricular cardiomyocytes with adenoviruses expressing the FL, 110 and 40 kDa fragments of cMyBP-C, and measured cytotoxicity, Ca2+ transients, contractility, and protein-protein interactions. Here we show that expression of 40 kDa fragments in neonatal rat ventricular cardiomyocytes significantly increases LDH release and caspase 3 activity, significantly reduces cell viability, and impairs Ca2+ handling. Adult cardiomyocytes expressing 40 kDa fragments exhibited similar impairment of Ca2+ handling along with a significant reduction of sarcomere length shortening, relaxation velocity, and contraction velocity. Pull-down assays using recombinant proteins showed that the 40 kDa fragment binds significantly to sarcomeric actin, comparable to C0-C2 domains. In addition, we discovered several acetylation sites within the 40 kDa fragment that could potentially affect actomyosin function. Altogether, our data demonstrate that the 40 kDa cleavage fragments of cMyBP-C are toxic to cardiomyocytes and significantly impair contractility and Ca2+ handling via inhibition of actomyosin function. By elucidating the deleterious effects of endogenously expressed cMyBP-C N-terminal fragments on sarcomere function, these data contribute to the understanding of contractile dysfunction following myocardial injury.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [31] Updating the Physiology and Pathophysiology of Cardiac Myosin-Binding Protein-C
    LeWinter, Martin M.
    Palmer, Bradley M.
    CIRCULATION-HEART FAILURE, 2015, 8 (03) : 417 - 421
  • [32] Phosphorylation and function of cardiac myosin binding protein-C in health and disease
    Barefield, David
    Sadayappan, Sakthivel
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (05) : 866 - 875
  • [33] Post-translational regulation of cardiac myosin binding protein-C: A graphical review
    Main, Alice
    Fuller, William
    Baillie, George S.
    CELLULAR SIGNALLING, 2020, 76
  • [34] Altered interactions between cardiac myosin binding protein-c and α-cardiac actin variants associated with cardiomyopathies
    Chow, Melissa L.
    Shaffer, Justin F.
    Harris, Samantha P.
    Dawson, John F.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 550 : 28 - 32
  • [35] N-Terminal Fragment of Cardiac Myosin Binding Protein C Modulates Cooperative Mechanisms of Thin Filament Activation in Atria and Ventricles
    Kochurova, Anastasia M.
    Beldiia, Evgenia A.
    Nefedova, Victoria V.
    Ryabkova, Natalia S.
    Yampolskaya, Daria S.
    Matyushenko, Alexander M.
    Bershitsky, Sergey Y.
    Kopylova, Galina V.
    Shchepkin, Daniil V.
    BIOCHEMISTRY-MOSCOW, 2024, 89 (01) : 116 - 129
  • [36] C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation
    Harris, Samantha P.
    Belknap, Betty
    Van Sciver, Robert E.
    White, Howard D.
    Galkin, Vitold E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (06) : 1558 - 1563
  • [37] Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations
    Wong, Fiona L.
    Bunch, Thomas A.
    Lepak, Victoria C.
    Steedman, Allison L.
    Colson, Brett A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2024, 186 : 125 - 137
  • [38] Cardiac Myosin Binding Protein-C Plays No Regulatory Role in Skeletal Muscle Structure and Function
    Lin, Brian
    Govindan, Suresh
    Lee, Kyounghwan
    Zhao, Piming
    Han, Renzhi
    Runte, K. Elisabeth
    Craig, Roger
    Palmer, Bradley M.
    Sadayappan, Sakthivel
    PLOS ONE, 2013, 8 (07):
  • [39] The extent of cardiac myosin binding protein-C phosphorylation modulates actomyosin function in a graded manner
    Weith, Abbey E.
    Previs, Michael J.
    Hoeprich, Gregory J.
    Previs, Samantha Beck
    Gulick, James
    Robbins, Jeffrey
    Warshaw, David M.
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2012, 33 (06) : 449 - 459
  • [40] Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy
    Mamidi, Ranganath
    Li, Jiayang
    Gresham, Kenneth S.
    Stelzer, Julian E.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2014, 466 (02): : 225 - 230